Scarica l'app Stockscreener
40.48
3.74%
1.4487
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Biohaven Ltd Borsa (BHVN) Ultime notizie
Biohaven Ltd. (NYSE:BHVN) Stock Holdings Raised by ARS Investment Partners LLC - MarketBeat
Biohaven Ltd. (NYSE:BHVN) Given Average Rating of "Buy" by Brokerages - MarketBeat
Insider Stock Buying Reaches US$23.8m On Biohaven - Simply Wall St
Biohaven’s stock surges as treatment slows progress of neurological disorder - MSN
Biohaven (NYSE:BHVN) Trading Down 6.4%Here's What Happened - MarketBeat
Biohaven Refines Epilepsy Trial Design With Patient-Centric Focus - Clinical Leader
Motor Neuron Disease Clinical and Non-Clinical Studies, Key - openPR
Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals - News & Insights
Biohaven (NYSE:BHVN) Stock Price Down 6.4%Should You Sell? - MarketBeat
Why Biohaven Ltd. Stocks Are Rising Now - TipRanks
What's Going On With Merus Stock Monday?Biohaven (NYSE:BHVN), Merus (NASDAQ:MRUS) - Benzinga
Biohaven & Merus Team Up to Develop Novel Bispecific ADC Therapies - Contract Pharma
Biohaven Showcases TRAP Degraders at J.P. Morgan Conference - TipRanks
Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generatio - PR Newswire
Merus and Biohaven Partner to Develop Next-Generation Cancer-Fighting ADC Therapies - StockTitan
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs - The Manila Times
Biohaven (NYSE:BHVN) Shares Gap DownHere's What Happened - MarketBeat
Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
JPMorgan Chase & Co. Increases Stock Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares - Yahoo Finance
Long Term Trading Analysis for (BHVN) - Stock Traders Daily
Biohaven Announces Conference Call to Discuss Topline Pivotal St - GuruFocus.com
Biohaven Stock Surges After Director Acquires Shares Worth Over $1M: Retail Sentiment Turns Bullish - MSN
Biohaven (NYSE:BHVN) Shares Gap Up on Insider Buying Activity - MarketBeat
John W. Childs Buys 29,000 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - MarketBeat
Biohaven Ltd. Stocks Surge Amid Positive Developments - TipRanks
Biohaven director John Childs acquires shares worth $1.04 million By Investing.com - Investing.com Nigeria
Biohaven director John Childs acquires shares worth $1.04 million - Investing.com
Biohaven Ltd. (NYSE:BHVN) Receives $63.00 Average Price Target from Brokerages - MarketBeat
Biohaven Enters Oversold Territory (BHVN) - Nasdaq
How To Trade (BHVN) - Stock Traders Daily
Geode Capital Management LLC Purchases 44,174 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Bernstein reiterates Outperform rating on Biohaven stock, sees strong upside potential By Investing.com - Investing.com South Africa
Biohaven (NYSE:BHVN) Stock Price Down 6.1%What's Next? - MarketBeat
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval - AOL
Bernstein reiterates Outperform rating on Biohaven stock, sees strong upside potential - Investing.com Australia
Biohaven's (BHVN) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Biohaven (NYSE:BHVN) Given Buy Rating at HC Wainwright - MarketBeat
Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Biohaven Pharma (BHVN) Reports Positive Phase 1 Degrader Data - StreetInsider.com
Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates - PR Newswire
Biohaven Ltd. (NYSE:BHVN) Holdings Boosted by Barclays PLC - MarketBeat
Wellington Management Group LLP Boosts Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven's SWOT analysis: neurological drug developer's stock poised for growth - Investing.com
12 Best Weight Loss Stocks to Buy According to Hedge Funds - Insider Monkey
State Street Corp Sells 393,278 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven Announces Proposed Public Offering of Common Shares - The Eastern Progress Online
0.78%
8.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):